Intractable middle ear effusion in EGPA patients might cause permanent hearing loss: a case-control study.

Publication Year: 2022

DOI:
10.1186/s13223-022-00706-x

PMCID:
PMC9357339

PMID:
35933390

Journal Information

Full Title: Allergy Asthma Clin Immunol

Abbreviation: Allergy Asthma Clin Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe Institutional Review Board (IRB) of Samsung Medical Center approved this study (IRB no. 2019–07-032) and waived informed consent due to the retrospective nature. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025